Medscape Conference Coverage, based on selected sessions at the:
American Academy of Addiction Psychiatry (AAAP) 18th Annual Meeting & Symposium
November 29, 2007 - December 2, 2007, Coronado, California
This activity is not sanctioned by, nor a part of, the American Academy of Addiction Psychiatry.
Conference News- New Treatment for Depressed, Anxious Teen Addicts Shows PromiseA new substance-abuse outpatient treatment program for adolescents with coexisting mood and/or anxiety problems shows promise in early evaluation.
Medscape Medical News, December 13, 2007 - Depression and Suicide Risk Identified in Methamphetamine UsersA high depression inventory score and past suicide attempts predicted depression and suicide attempts among methamphetamine users, in a large trial.
Medscape Medical News, December 12, 2007 - Buprenorphine-Naloxone Treatment Effective for Teen Opioid AbusersTeen opioid abusers on buprenorphine-naloxone for 12 weeks vs 2 weeks had better treatment outcomes, but relapse was high in both groups, in a recent trial.
Medscape Medical News, December 11, 2007 - Trazodone Improves Sleep, but Decreases Abstinence in Recovering AlcoholicsIn a recent clinical trial, despite short-term benefit in sleep quality, trazodone impeded improvements in alcohol consumption in recovering insomniac alcoholics.
Medscape Medical News, December 7, 2007 - A Cocaine Vaccine and Disulfiram Show Promise for Cocaine DependenceA cocaine vaccine and disulfiram show promise for treating cocaine dependence, according to a keynote address at the AAAP meeting.
Medscape Medical News, December 6, 2007 - Psychotherapy Appears Useful for Treating Methamphetamine AbusePromising psychotherapy and potential pharmacological therapies for treating methamphetamine abuse were discussed in a symposium at the AAAP meeting.
Medscape Medical News, December 6, 2007 - Perceived Rewards, Problems, Among Ketamine Users IdentifiedKetamine is not just a "club drug," and more frequent use is linked with communication and abdominal problems, according a survey of users in Toronto.
Medscape Medical News, December 3, 2007
|
Legal Disclaimer
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Academy of Addiction Psychiatry. These materials and the related activity are not sanctioned by the American Academy of Addiction Psychiatry or the commercial supporter of the conference and do not constitute an official part of that conference.
Copyright © 2007 Medscape.
